Castleview Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-6
Closed -$277 709
2022
Q4
$277 Buy
+6
New +$277 ﹤0.01% 605